We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 04, 2021

Concomitant COVID-19 and Influenza Vaccine

The Lancet


Additional Info

The Lancet
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
Lancet 2021 Nov 11;[EPub Ahead of Print], R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, M Clout, L Culliford, SR Emmett, J Garstang, L Gbadamoshi, B Hallis, RA Harris, D Hutton, N Jacobsen, K Joyce, R Kaminski, V Libri, A Middleditch, L McCullagh, E Moran, A Phillipson, E Price, J Ryan, R Thirard, R Todd, MD Snape, D Tucker, RL Williams, JS Nguyen-Van-Tam, A Finn, CA Rogers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading